Woodline Partners’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Hold |
113,517
| – | – | 0.01% | 757 |
|
|
2025
Q1 | $1.54M | Buy |
113,517
+13,517
| +14% | +$184K | 0.01% | 706 |
|
|
2024
Q4 | $2.04M | Buy |
+100,000
| New | +$2.04M | 0.01% | 644 |
|
|
2024
Q3 | – | Sell |
-56,554
| Closed | -$1.31M | – | 623 |
|
|
2024
Q2 | $1.31M | Sell |
56,554
-452,011
| -89% | -$10.5M | 0.01% | 444 |
|
|
2024
Q1 | $10.4M | Buy |
508,565
+310,981
| +157% | +$6.38M | 0.1% | 261 |
|
|
2023
Q4 | $4.24M | Sell |
197,584
-653,905
| -77% | -$14M | 0.05% | 331 |
|
|
2023
Q3 | $17.6M | Buy |
851,489
+739,277
| +659% | +$15.3M | 0.21% | 146 |
|
|
2023
Q2 | $3.31M | Buy |
112,212
+11,901
| +12% | +$351K | 0.04% | 357 |
|
|
2023
Q1 | $2.31M | Buy |
+100,311
| New | +$2.31M | 0.03% | 399 |
|
|
2022
Q4 | – | Sell |
-444,256
| Closed | -$13.6M | – | 776 |
|
|
2022
Q3 | $13.6M | Buy |
444,256
+263,284
| +145% | +$8.08M | 0.19% | 155 |
|
|
2022
Q2 | $5.33M | Sell |
180,972
-75,706
| -29% | -$2.23M | 0.08% | 250 |
|
|
2022
Q1 | $8.26M | Buy |
256,678
+204,224
| +389% | +$6.57M | 0.13% | 188 |
|
|
2021
Q4 | $2.34M | Buy |
+52,454
| New | +$2.34M | 0.03% | 398 |
|